Trials / Completed
CompletedNCT03092973
Carotid Intima Media Thickness (CIMT) in Epistaxis
Carotid Intima Media Thickness in Patients With Epistaxis: a Surrogate Marker for Generalised Atherosclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Epistaxis is a very frequent emergency among adults and often needs specialised treatment in an ENT-department. Among others, atherosclerosis is often named as a reason for an increased risk for Epistaxis. To evaluate whether or not this is the case, the investigators examined the carotid intima media thickness via ultrasound in patients who were treated in the ENT-department of the University Hospital of Zurich.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Ultrasound |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-06-30
- Completion
- 2017-06-30
- First posted
- 2017-03-28
- Last updated
- 2017-10-30
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03092973. Inclusion in this directory is not an endorsement.